Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
227
datasets available to search
ShareScore release 0.9.0
Dataset results
227 results for “tool validation”
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT03142711. IPD Sharing: NO. Countries: 2. Publications: 0.
Validation of DigiCog and Konectom Tools to Support Digitalized Clinical Assessment in Multiple Sclerosis
ClinicalTrials.gov study NCT04756700. IPD Sharing: YES. Countries: 1. Publications: 0.
Validating the Ain Shams Cognitive Assessment Tool
ClinicalTrials.gov study NCT06789094. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Examine the Validity of a Panel of Objective Burn Scar Measurement Tools
ClinicalTrials.gov study NCT05126017. IPD Sharing: NO. Countries: 0. Publications: 0.
Assessing the Validity of the PAP Problems Triage Tool in Patients With PAP Treatment for Obstructive Sleep Apnea
ClinicalTrials.gov study NCT05530967. IPD Sharing: NO. Countries: 0. Publications: 0.
Prospective Validation Study of an E-health Tool for Patient Selection for SCS
ClinicalTrials.gov study NCT06853795. IPD Sharing: NO. Countries: 0. Publications: 0.
Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
ClinicalTrials.gov study NCT06010550. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Evaluation and Validation of Novel Diagnostic Tool for Allergists (AbioSCOPE)
ClinicalTrials.gov study NCT03599908. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Mortality Risk Assessment by Skilled Staff Compared to Existing Validated Tools in Skilled Nursing Departments
ClinicalTrials.gov study NCT06675071. IPD Sharing: NO. Countries: 0. Publications: 0.
Validation of the STAMP Screening Tool
ClinicalTrials.gov study NCT01584310. IPD Sharing: Not stated. Countries: 0. Publications: 0.
VALIDATE: Virtual Agent Linked Intelligent Disease Assessment Tool Engine
ClinicalTrials.gov study NCT03153618. IPD Sharing: NO. Countries: 0. Publications: 0.
A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pe
ClinicalTrials.gov study NCT04254991. IPD Sharing: NO. Countries: 0. Publications: 0.
Ataset of the publication "Is red distribution width a valid tool to predict impaired iron transport in heart failure?"
<p>Background: Impaired iron transport (IIT) is a form of iron deficiency (ID) defined as transferrin saturation (TSAT) < 20% irrespective of serum ferritin levels. It is frequently observed in heart failure (HF) where it negatively affects prognosis irrespective of anaemia. Objectives: In this retrospective study we searched for a surrogate biomarker of IIT. Methods: We tested the predictive power of red distribution width (RDW), mean corpuscular volume (MCV) and mean corpuscular haemoglobin concentration (MCHC) to detect IIT in 797 non-anaemic HF patients. Results: At ROC analysis, RDW provided the best AUC (0.6928). An RDW cut-off value of 14.2% identified patients with IIT, with positive and negative predictive values of 48 and 80%, respectively. Comparison between the true and false negative groups showed that estimated glomerular filtration rate (eGFR) was significantly higher (p = 0.0092) in the true negative vs. false negative group. Therefore, we divided the study population according to eGFR value: 109 patients with eGFR ≥ 90 ml/min/1.73 m2, 318 patients with eGFR 60-89 ml/min/1.73 m2, 308 patients with eGFR 30-59 ml/min/1.73 m2 and 62 patients with eGFR < 30 ml/min/1.73 m2. In the first group, positive and negative predictive values were 48 and 81% respectively, 51 and 85% in the second group, 48 and 73% in the third group and 43 and 67% in the fourth group. Conclusion: RDW may be seen as a reliable marker to exclude IIT in non-anaemic HF patients with eGFR ≥60 ml/min/1.73 m2.</p>
In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping
ClinicalTrials.gov study NCT07011212. IPD Sharing: NO. Countries: 0. Publications: 0.
Dataset related to article "Is the Instability Severity Index Score a Valid Tool for Predicting Failure After Primary Arthroscopic Stabilization for Anterior Glenohumeral Instability?"
<p>This record contains raw data related to article “Is the Instability Severity Index Score a Valid Tool for Predicting Failure After Primary Arthroscopic Stabilization for Anterior Glenohumeral Instability?”.</p> <p><strong>Abstract</strong></p> <p><strong>Purpose: </strong>To assess the validity of the Instability Severity Index Score in predicting the rate of recurrence of dislocation in patients undergoing arthroscopic Bankart repair.</p> <p><strong>Methods: </strong>The inclusion criteria were recurrent anterior traumatic glenohumeral instability and a minimum follow-up of 5 years. According to the preoperative Instability Severity Index Score, patients were divided into the following groups: ≤3 points (A), 4 to 6 points (B), and >6 points (C). The recurrence rate was determined by telephone interviews. The estimated overall rate of success at 5 years was defined as the estimated overall percentage of patients free of recurrence at 5 years.</p> <p><strong>Results: </strong>Six hundred seventy patients (572 men and 98 women) were included. The average age was 27 years (range, 18 to 39 years) at the time of surgery. One hundred fourteen of 670 patients had a recurrence of instability, with an overall recurrence rate of 17% (95% confidence interval [CI] 14.2%-19.9%). The Instability Severity Index Score had a significant association with recurrence. Compared with patients in group A, those in group B had double the risk of recurrence (hazard ratio [HR] = 2.43, 95% CI 1.38-4.28, P = .002), and patients in group C a 9 times greater risk of recurrence (HR = 9.42, 95% CI 5.20-17.7, P < .001). The estimated overall rate of success at 5 years was 84.8% (95% CI 81.8-87.3). The rate of success with an Instability Severity Index Score ≤3 points was 93.7% (95% CI 89.6-96.2), but it dropped to 85.7% (95% CI 81.7-88.9) in those with an Instability Severity Index Score of 4 to 6 points and became 54.6% (95% CI 42.8-64.9) in those with an Instability Severity Index Score >6 points. On multivariable analysis, the Instability Severity Index Score was found to significantly affect the risk of recurrence, corrected by type of sport and glenoid bone loss.</p> <p><strong>Conclusions: </strong>The Instability Severity Index Score is a validated tool with which to assess the recurrence rate of dislocation after arthroscopic surgery in patients with shoulder instability. Arthroscopic stabilization in patients with an Instability Severity Index Score ≤3 is associated with a significantly lower risk of recurrence of glenohumeral instability compared with that in patients with an Instability Severity Index Score >3 points.</p> <p><strong>Level of evidence: </strong>III, case-control study.</p>
Cross-cultural adaptation and validation of a surgical neonatal nursing workload tool to the Italian context: The Italian Win-nipeg Surgical Complex Assessment of Neonatal Nursing Needs Tool
Open the record for dataset details and reuse information.
PDS Software Release Validation Tool (2.0.1) and Product Tools (2.0.1)
PDS Validation Tool (2.0.1) and Product Tools (2.0.1)
PDS Software Release Validation Tool (1.2.0) and Product Tools (1.2.0)
PDS Validation Tool (1.2.0) and Product Tools (1.2.0)
PDS Software Release Validation Tool (1.1.0) and Product Tools (1.1.0)
PDS Validation Tool (1.1.0) and Product Tools (1.1.0)
PDS Software Release Validation Tool (2.1.0)
PDS Validation Tool (2.1.0)
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.